Skip to content Skip to sidebar Skip to footer

Global Liposomes Drug Delivery Market Data Download UPDATED

Global Liposomes Drug Delivery Market Data Download

  • Seamless access

    Admission through your establishment

Elsevier

Biomaterials

Leading Opinion

Positioning metal-organic framework nanoparticles within the context of drug delivery – A comparison with mesoporous silica nanoparticles and dendrimers

Abstruse

Nanotechnology enables the creation of delivery vehicles able to overcome physiologically imposed barriers, assuasive new approaches for reducing the unwanted side furnishings of systemic delivery of drug, increasing targeting efficiency and so improving therapy efficacy. Owing to the considerable advances in material sciences and pharmaceutics, a broad range of different inorganic or organic drug nanocarriers have been developed. Furthermore, researchers have shown that the combination of inorganic and organic chemistries in one unmarried cloth, named metallic-organic framework (MOF), offers structural designability at the molecular level together with tunable porosity and chemical functionalisability. While the MOF size can be controlled at the nanometer calibration, these features are of paramount interest in the development of the next generation of drug delivery systems. After a brusk state-of-the-art about MOF engineering science and within the drug delivery context, this paper discusses the benefits of using MOF nanoparticles compared to dendrimers and mesoporous silica nanoparticles in order to understand the challenges that must however exist overcome.

Introduction

In light of the increasing number of publications over the last decade, metal-organic frameworks (MOFs), as well known as porous coordination polymers, have emerged as a promising new grade of porous materials. While their potential applications in various fields, ranging from gas storage to free energy technologies including catalysis, take been highlighted and reported in several articles and themed problems [1], [ii], [three], [4], [five], [6], [seven], MOF materials, and in particular their nanometric counterparts, notwithstanding take to exist discussed relative to other fabric classes in terms of their construction-to-performance relationships. This perspective article thus aims at describing the benefits of using MOF nanoparticles (MOF NPs or nanoMOFs) in the field of biomedicine, and putting into perspective their properties in the context of the ones of other NPs.

The use of nanoparticles (NPs) relies on their properties that fundamentally differ from those of the corresponding three-dimensional infinite solids [eight]. These properties are size- and surface-dependent and kickoff to get pregnant at a length scale below 100 nm, which defines the arbitrary just scientific accepted definition of nanomaterials and NPs in particular. The virtually important feature of NPs is their large external surface area, i.due east. their high surface-to-volume ratio, which dominates NPs physicochemical backdrop. As a consequence of an increased number of surface atoms, NPs are typically highly chemically reactive, have a lower melting indicate in comparison to the bulk material, and tend to form aggregates [8]. The NPs surface interface likewise drives the interactions of NPs with their environment. This is a valuable property equally the surface-interface can exist engineered to ameliorate chemical and colloidal stability for targeting specific problems, as for case concomitant transport and delivery of bioactive molecules, which are typical tasks defining the nanocarrier concept [9], [10], [11], [12], [13], [14], [15], [16], [17], [xviii], [19], [20], [21]. The unlike nanomaterial classes developed to date tin can be categorized into NP either purely organic nanosystems including liposomes, dendrimers, micelles, and polymeric capsules, or purely inorganic NPs such equally quantum dots, noble metal NPs, fe oxide NPs, silica NPs and upconversion NPs [9], [x], [11], [18]. In general inorganic NPs require an organic surface coating warranting for colloidal stability, as in the context of biological media also inorganic NPs inevitable will comprise organic molecules adsorbed to their surface [8], [22]. MOF NPs or nanoMOFs define a new course of hybrid nanomaterials as they consist of inorganic edifice units (e.chiliad. metal oxide clusters) covalently continued by organic building units (e.g. organic linkers) at the nanometer level [23], [24], [25], [26], [27], [28], [29], [xxx], [31]. Hence, MOF NPs combine the richness of bulk MOF chemical science with the benign surface- and size-dependent properties of the nanoworld (Fig. 1). Bringing together both of these worlds leads to a flourishing interdisciplinary field of research based on the interconnection of chemical science, physics, and material sciences, which can have diverse practical outcomes relevant to in various sectors of applications and in particular in biomedicine.

Section snippets

Magic bullet concept and scope of the paper

The development of efficient drug delivery systems is an of import topic of biomedical research in order to ensure a quicker and forceful therapeutic outcome. Any the assistants route used to deliver the drug, i.east. oral, nasal, skin, pulmonary or intravenous, drugs in general have to cantankerous multiple biological barriers in order to achieve their intended site of activeness (Fig. 2) [32], [33]. Furthermore, systemic drug assistants suffers from critical issues as poor solubility, limited

MOF nanoparticles as future nanocarriers

MOFs are hybrid materials constructed via strong metal-ligand covalent bonds betwixt inorganic clusters and organic linkers, which are organized in a periodic way to create porous and crystalline 3-dimensional framework (Fig. 3) [5], [vi], [46], [47]. In full general, MOFs can be made of numerous metallic ions of the periodic table, especially those that are di-, tri- or tetravalent and that form inorganic clusters during the synthesis (Fig. three) [48]. The organic linker, for its part, is preformed

Conclusion and outlook

Taken all together, MOF NPs appear as a very promising drug delivery platform that still needs to be fully exploited to get closer to the concept of a "magic bullet" with universally improved backdrop as compared to other NP classes used in drug delivery. Their cardinal reward is their hybrid nature relying on the synergistic combination of inorganic and organic chemistry that allows very high porosities and the incorporation of a big variety of functional groups. On one hand, their assembly

Acknowledgements

Parts of this work were funded by the European Commission (projection FutureNanoNeeds to WJP). SW is grateful for financial back up from the Deutsche Forschungsgemeinschaft through DFG-project WU 622/4-i. ML is grateful for the financial support of a Concerted Enquiry Action from the University of Liège, Kingdom of belgium (CRA2015 – Projection icFlow). Finally, the authors would like to thank Prof. Omar M. Yaghi (UC Berkeley) for his valuable constructive comments.

References (193)

  • et al.

    Dendrimers—branching out from curiosities into new technologies

    Prog. Polym. Sci.

    (1998)

  • V. Mamaeva et al.

    Mesoporous silica nanoparticles in medicine-Contempo advances

    Adv. Drug Deliv. Rev.

    (2013)

  • E.Grand. Johansson et al.

    Synthesis and characterization of large mesoporous silica SBA-xv sheets with ordered accessible 18 nm pores

    Mater. Lett.

    (2009)

  • S. Svenson

    Dendrimers as versatile platform in drug delivery applications

    Eur. J. Pharm. Biopharm.

    (2009)

  • B.K. Nanjwade et al.

    Dendrimers: emerging polymers for drug-delivery systems

    Eur. J. Pharm. Sci.

    (2009)

  • P. Falcaro et al.

    Application of metal and metal oxide [email protected]

    Coord. Chem. Rev.

    (2016)

  • Yard.J. Akhtar et al.

    Targeted anticancer therapy: overexpressed receptors and nanotechnology

    Clin. Chim. Acta

    (2014)

  • Y. Barenholz

    Doxil – the outset FDA-canonical nano-drug: lessons learned

    J. Command. Release

    (2012)

  • M.J. Hawkins et al.

    Protein nanoparticles equally drug carriers in clinical medicine

    Adv. Drug Deliv. Rev.

    (2008)

  • C.M. Dawidczyk et al.

    Country-of-the-art in blueprint rules for drug commitment platforms: lessons learned from FDA-approved nanomedicines

    J. Control. Release

    (2014)

  • A.H. Faraji et al.

    Nanoparticles in cellular drug delivery

    Bioorg. Med. Chem.

    (2009)

  • R. Fischer et al.

    Special issue: new generations of porous metal-organic frameworks

    Microporous Mesoporous Mater.

    (2015)

  • T.D. Bennett et al.

    Flexibility and disorder in metallic–organic frameworks

    Dalt. Trans.

    (2016)

  • J.R. Long et al.

    The pervasive chemical science of metal-organic frameworks

    Chem. Soc. Rev.

    (2009)

  • J.-C. Tan et al.

    Metal-Organic frameworks and hybrid materials: from fundamentals to applications

    CrystEngComm

    (2015)

  • H.C. Zhou et al.

    Introduction to metal-organic frameworks

    Chem. Rev.

    (2012)

  • H.C. Zhou et al.

    Metal–organic frameworks (MOFs)

    Chem. Soc. Rev.

    (2014)

  • 1000. Peplow

    The hole story

    Nature

    (2015)

  • H. Goesmann et al.

    Nanoparticulate functional materials

    Angew. Chem. – Int. Ed.

    (2010)

  • F. Caruso et al.

    Nanomedicine

    Chem. Soc. Rev.

    (2012)

  • Westward. Lin

    Introduction: nanoparticles in medicine

    Chem. Rev.

    (2015)

  • X. Chen et al.

    Guest editorial- theranostic nanomedicine

    Acc. Chem. Res.

    (2011)

  • T.Yard. Allen et al.

    Drug commitment systems: entering the mainstream

    Scientific discipline

    (2004)

  • C. McAllister et al.

    Impact of nanotechnology on hair attributes

    ACS Nano

    (2009)

  • S. Mitragotri et al.

    Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

    Nat. Rev. Drug Discov.

    (2014)

  • S. Mura et al.

    Stimuli-responsive nanocarriers for drug delivery

    Nat. Mater.

    (2013)

  • Z. Li et al.

    Mesoporous silica nanoparticles in biomedical applications

    Chem. Soc. Rev.

    (2012)

  • D. Peer et al.

    Nanocarriers as an emerging platform for cancer therapy

    Nat. Nanotechnol.

    (2007)

  • B. Pelaz et al.

    The land of nanoparticle-based nanoscience and biotechnology: progress, promises, and challenges

    ACS Nano

    (2012)

  • A. Schroeder et al.

    Treating metastatic cancer with nanotechnology

    Nat. Rev. Cancer

    (2011)

  • Y. Zhao et al.

    The challenge to chronicle the physicochemical backdrop of colloidal nanoparticles to their cytotoxicity

    Acc. Chem. Res.

    (2012)

  • A.M. Spokoyny et al.

    Infinite coordination polymer nano- and microparticle structures

    Chem. Soc. Rev.

    (2009)

  • A. Carné et al.

    Nanoscale metal–organic materials

    Chem. Soc. Rev.

    (2011)

  • P. Horcajada et al.

    Metallic-organic frameworks in biomedicine

    Chem. Rev.

    (2012)

  • P. Falcaro et al.

    MOF positioning engineering science and device fabrication

    Chem. Soc. Rev.

    (2014)

  • C. He et al.

    Nanomedicine applications of hybrid nanomaterials congenital from metal-ligand coordination bonds: nanoscale metal-organic frameworks and nanoscale coordination polymers

    Chem. Rev.

    (2015)

  • M. Giménez-Marqués et al.

    Nanostructured metal-organic frameworks and their bio-related applications

    Coord. Chem. Rev.

    (2015)

  • B. Rungtaweevoranit et al.

    Cooperative effects at the interface of nanocrystalline metal–organic frameworks

    Nano Res.

    (2016)

  • Southward. Furukawa et al.

    Structuring of metallic–organic frameworks at the mesoscopic/macroscopic scale

    Chem. Soc. Rev.

    (2014)

  • Southward. Hermes et al.

    Trapping metallic-organic framework nanocrystals: an in-situ fourth dimension-resolved lite scattering report on the crystal growth of MOF-5 in solution

    J. Am. Chem. Soc.

    (2007)

  • North. Desai

    Challenges in development of nanoparticle-based therapeutics

    AAPS J.

    (2012)

  • E. Blanco et al.

    Principles of nanoparticle pattern for overcoming biological barriers to drug delivery

    Nat. Biotechnol.

    (2015)

  • C. Baleiz

    Hybrid smart mesoporous silica nanoparticles for theranostics

    Nanomedicine

    (2015)

  • C. Argyo et al.

    Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery

    Chem. Mater.

    (2014)

  • Eastward. Miele et al.

    Albumin-leap formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer

    Int. J. Nanomed.

    (2009)

  • Thousand. Park

    Facing the truth near nanotechnology in drug delivery

    ACS Nano

    (2013)

  • R.A. Petros et al.

    Strategies in the design of nanoparticles for therapeutic applications

    Nat. Rev. Drug Discov.

    (2010)

  • E. Wagner

    Polymers for siRNA commitment: inspired past viruses to be targeted, dynamic, and precise

    Acc. Chem. Res.

    (2012)

  • A. Nel et al.

    Environmental health and safe considerations for nanotechnology

    Acc. Chem. Res.

    (2013)

  • A. Nel

    Toxic potential of materials at the nanolevel

    Scientific discipline

    (2006)

  • Cited by (170)

    View full text

    DOWNLOAD HERE

    Posted by: farrenasted1989.blogspot.com

    Post a Comment for "Global Liposomes Drug Delivery Market Data Download UPDATED"